<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD09470000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P05181</UniProt_ID>
  <Seq_Length>493</Seq_Length>
  <Molecule_Weight>56849</Molecule_Weight>
  <KEGG_ID>hsa:1571</KEGG_ID>
  <Orthology_ID>K07415</Orthology_ID>
  <Function_Summary>Metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Inactivates a number of drugs and xenobiotics and also bioactivates many xenobiotic substrates to their hepatotoxic or carcinogenic forms.</Function_Summary>
  <Catalytic_Mechanism>4-nitrophenol + NADPH + O(2) = 4-nitrocatechol + NADP(+) + H(2)O.</Catalytic_Mechanism>
  <Pfam_ID>PF00067:p450</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>1</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Cytochrome P450-J</Alias>
      <Alias>CYPIIE1</Alias>
      <Alias>Cytochrome P450 2E1, N-terminally processed</Alias>
      <Alias>4-nitrophenol 2-hydroxylase</Alias>
      <Alias>1.14.13.n7&lt;/ecNumber</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Any molecular entity that serves as an electron acceptor and electron donor in an electron transport system.</Detail>
      <Keyword>Electron carrier activity</Keyword>
      <Ontology_ID>GO:0009055</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from reduced flavin or flavoprotein and one other donor, and one atom of oxygen is incorporated into one donor.</Detail>
      <Keyword>Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen</Keyword>
      <Ontology_ID>GO:0016712</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with heme, any compound of iron complexed in a porphyrin (tetrapyrrole) ring.</Detail>
      <Keyword>Heme binding</Keyword>
      <Ontology_ID>GO:0020037</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the incorporation of one atom from molecular oxygen into a compound and the reduction of the other atom of oxygen to water.</Detail>
      <Keyword>Monooxygenase activity</Keyword>
      <Ontology_ID>GO:0004497</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of an oxidation-reduction (redox) reaction in which hydrogen or electrons are transferred from NADH or NADPH and one other donor, and one atom of oxygen is incorporated into one donor.</Detail>
      <Keyword>Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NADH or NADPH as one donor, and incorporation of one atom of oxygen</Keyword>
      <Ontology_ID>GO:0016709</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with oxygen (O2).</Detail>
      <Keyword>Oxygen binding</Keyword>
      <Ontology_ID>GO:0019825</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with iron (Fe) ions.</Detail>
      <Keyword>Iron ion binding</Keyword>
      <Ontology_ID>GO:0005506</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>219</Position>
      <Original>Asn</Original>
      <Variation>Asp</Variation>
    </Muntion>
    <Muntion>
      <Position>389</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>457</Position>
      <Original>His</Original>
      <Variation>Leu</Variation>
    </Muntion>
    <Muntion>
      <Position>179</Position>
      <Original>Val</Original>
      <Variation>Ile</Variation>
    </Muntion>
    <Muntion>
      <Position>366</Position>
      <Original>Ser</Original>
      <Variation>Cys</Variation>
    </Muntion>
    <Muntion>
      <Position>76</Position>
      <Original>Arg</Original>
      <Variation>His</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving heterocyclic compounds, those with a cyclic molecular structure and at least two different atoms in the ring (or rings).</Detail>
      <Keyword>Heterocycle metabolic process</Keyword>
      <Ontology_ID>GO:0046483</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving triglyceride, any triester of glycerol. The three fatty acid residues may all be the same or differ in any permutation. Triglycerides are important components of plant oils, animal fats and animal plasma lipoproteins.</Detail>
      <Keyword>Triglyceride metabolic process</Keyword>
      <Ontology_ID>GO:0006641</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving steroids, compounds with a 1,2,cyclopentanoperhydrophenanthrene nucleus.</Detail>
      <Keyword>Steroid metabolic process</Keyword>
      <Ontology_ID>GO:0008202</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving a xenobiotic compound, a compound foreign to living organisms. Used of chemical compounds, e.g. a xenobiotic chemical, such as a pesticide.</Detail>
      <Keyword>Xenobiotic metabolic process</Keyword>
      <Ontology_ID>GO:0006805</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic nitrogen stimulus. An organic nitrogen compound is formally a compound containing at least one carbon-nitrogen bond.</Detail>
      <Keyword>Response to organic nitrogen</Keyword>
      <Ontology_ID>GO:0010243</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving a drug, a substance used in the diagnosis, treatment or prevention of a disease; as used here antibiotic substances (see antibiotic metabolism) are considered to be drugs, even if not used in medical or veterinary practice.</Detail>
      <Keyword>Drug metabolic process</Keyword>
      <Ontology_ID>GO:0017144</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ozone stimulus.</Detail>
      <Keyword>Response to ozone</Keyword>
      <Ontology_ID>GO:0010193</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an ethanol stimulus.</Detail>
      <Keyword>Response to ethanol</Keyword>
      <Ontology_ID>GO:0045471</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving monoterpenoid compounds, terpenoids having a C10 skeleton.</Detail>
      <Keyword>Monoterpenoid metabolic process</Keyword>
      <Ontology_ID>GO:0016098</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving small molecules, any monomeric molecule of small relative molecular mass.</Detail>
      <Keyword>Small molecule metabolic process</Keyword>
      <Ontology_ID>GO:0044281</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A metabolic process that results in the removal or addition of one or more electrons to or from a substance, with or without the concomitant removal or addition of a proton or protons.</Detail>
      <Keyword>Oxidation-reduction process</Keyword>
      <Ontology_ID>GO:0055114</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.</Detail>
      <Keyword>Response to drug</Keyword>
      <Ontology_ID>GO:0042493</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>129</Position>
      <PTM_Type>Phosphoserine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MSALGVTVALLVWAAFLLLVSMWRQVHSSWNLPPGPFPLPIIGNLFQLELKNIPKSFTRLAQRFGPVFTLYVGSQRMVVMHGYKAVKEALLDYKDEFSGRGDLPAFHAHRDRGIIFNNGPTWKDIRRFSLTTLRNYGMGKQGNESRIQREAHFLLEALRKTQGQPFDPTFLIGCAPCNVIADILFRKHFDYNDEKFLRLMYLFNENFHLLSTPWLQLYNNFPSFLHYLPGSHRKVIKNVAEVKEYVSERVKEHHQSLDPNCPRDLTDCLLVEMEKEKHSAERLYTMDGITVTVADLFFAGTETTSTTLRYGLLILMKYPEIEEKLHEEIDRVIGPSRIPAIKDRQEMPYMDAVVHEIQRFITLVPSNLPHEATRDTIFRGYLIPKGTVVVPTLDSVLYDNQEFPDPEKFKPEHFLNENGKFKYSDYFKPFSTGKRVCAGEGLARMELFLLLCAILQHFNLKPLVDPKDIDLSPIHIGFGCIPPRYKLCVIPRS</Protein_Seq>
    <DNA_Seq>CTCCCGGGCTGGCAGCAGGGCCCCAGCGGCACCATGTCTGCCCTCGGAGTCACCGTGGCCCTGCTGGTGTGGGCGGCCTTCCTCCTGCTGGTGTCCATGTGGAGGCAGGTGCACAGCAGCTGGAATCTGCCCCCAGGCCCTTTCCCGCTTCCCATCATCGGGAACCTCTTCCAGTTGGAATTGAAGAATATTCCCAAGTCCTTCACCCGGTTGGCCCAGCGCTTCGGGCCGGTGTTCACGCTGTACGTGGGCTCGCAGCGCATGGTGGTGATGCACGGCTACAAGGCGGTGAAGGAAGCGCTGCTGGACTACAAGGACGAGTTCTCGGGCAGAGGCGACCTCCCCGCGTTCCATGCGCACAGGGACAGGGGAATCATTTTTAATAATGGACCTACCTGGAAGGACATCCGGCGGTTTTCCCTGACCACCCTCCGGAACTATGGGATGGGGAAACAGGGCAATGAGAGCCGGATCCAGAGGGAGGCCCACTTCCTGCTGGAAGCACTCAGGAAGACCCAAGGCCAGCCTTTCGACCCCACCTTCCTCATCGGCTGCGCGCCCTGCAACGTCATAGCCGACATCCTCTTCCGCAAGCATTTTGACTACAATGATGAGAAGTTTCTAAGGCTGATGTATTTGTTTAATGAGAACTTCCACCTACTCAGCACTCCCTGGCTCCAGCTTTACAATAATTTTCCCAGCTTTCTACACTACTTGCCTGGAAGCCACAGAAAAGTCATAAAAAATGTGGCTGAAGTAAAAGAGTATGTGTCTGAAAGGGTGAAGGAGCACCATCAATCTCTGGACCCCAACTGTCCCCGGGACCTCACCGACTGCCTGCTCGTGGAAATGGAGAAGGAAAAGCACAGTGCAGAGCGCTTGTACACAATGGACGGTATCACCGTGACTGTGGCCGACCTGTTCTTTGCGGGGACAGAGACCACCAGCACAACTCTGAGATATGGGCTCCTGATTCTCATGAAATACCCTGAGATCGAAGAGAAGCTCCATGAAGAAATTGACAGGGTGATTGGGCCAAGCCGAATCCCTGCCATCAAGGATAGGCAAGAGATGCCCTACATGGATGCTGTGGTGCATGAGATTCAGCGGTTCATCACCCTCGTGCCCTCCAACCTGCCCCATGAAGCAACCCGAGACACCATTTTCAGAGGATACCTCATCCCCAAGGGCACAGTCGTAGTGCCAACTCTGGACTCTGTTTTGTATGACAACCAAGAATTTCCTGATCCAGAAAAGTTTAAGCCAGAACACTTCCTGAATGAAAATGGAAAGTTCAAGTACAGTGACTATTTCAAGCCATTTTCCACAGGAAAACGAGTGTGTGCTGGAGAAGGCCTGGCTCGCATGGAGTTGTTTCTTTTGTTGTGTGCCATTTTGCAGCATTTTAATTTGAAGCCTCTCGTTGACCCAAAGGATATCGACCTCAGCCCTATACATATTGGGTTTGGCTGTATCCCACCACGTTACAAACTCTGTGTCATTCCCCGCTCATGAGTGTGTGGAGGACACCCTGAACCCCCCGCTTTCAAACAAGTTTTCAAATTGTTTGAGGTCAGGATTTCTCAAACTGATTCCTTTCTTTGCATATGAGTATTTGAAAATAAATATTTTCCCAGAATATAAATAAATCATCACATGATTATTTT</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Microsome membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Endoplasmic reticulum</CellLocal>
      <Ontology_ID>GO:0005783</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Endoplasmic reticulum membrane</CellLocal>
      <Ontology_ID>GO:0005789</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Intrinsic to endoplasmic reticulum membrane</CellLocal>
      <Ontology_ID>GO:0031227</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Golgi membrane</CellLocal>
      <Ontology_ID>GO:0000139</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Microsome</CellLocal>
      <Ontology_ID>GO:0005792</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Mitochondrion</CellLocal>
      <Ontology_ID>GO:0005739</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>CYP2E1</Gene_Name>
    <Gene_Alias>CYP2E</Gene_Alias>
    <Gene_ID>1571</Gene_ID>
    <Genbank_ACCN>NM_000773</Genbank_ACCN>
    <Protein_ACCN>NP_000764</Protein_ACCN>
    <HGNC_ID>2631</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/1571</Gene_URL>
    <UCSC_ID>uc001lnj.1</UCSC_ID>
    <EMBL_ID>ENSG00000130649</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Nonalcoholic Steatohepatitis</Disease_Name>
      <Disease_Detail>Nonalcoholic Steatohepatitis</Disease_Detail>
      <Disease_DB>NNL002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/nonalcoholic_steatohepatitis?search=CYP2E1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Methemoglobinemia</Disease_Name>
      <Disease_Detail>Methemoglobinemia</Disease_Detail>
      <Disease_DB>MTH007</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/methemoglobinemia?search=CYP2E1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Isoniazid Toxicity</Disease_Name>
      <Disease_Detail>Isoniazid Toxicity</Disease_Detail>
      <Disease_DB>ISN001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/isoniazid_toxicity?search=CYP2E1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lung Cancer</Disease_Name>
      <Disease_Detail>Lung Cancer</Disease_Detail>
      <Disease_DB>LNG032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lung_cancer?search=CYP2E1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Pancreatitis</Disease_Name>
      <Disease_Detail>Pancreatitis</Disease_Detail>
      <Disease_DB>PNC044</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/pancreatitis?search=CYP2E1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Alcohol-Related Birth Defect</Disease_Name>
      <Disease_Detail>Alcohol-Related Birth Defect</Disease_Detail>
      <Disease_DB>ALC001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/alcohol_related_birth_defect?search=CYP2E1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Liver Cirrhosis</Disease_Name>
      <Disease_Detail>Liver Cirrhosis</Disease_Detail>
      <Disease_DB>LVR012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/liver_cirrhosis?search=CYP2E1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Liver Disease</Disease_Name>
      <Disease_Detail>Liver Disease</Disease_Detail>
      <Disease_DB>LVR013</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/liver_disease?search=CYP2E1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Erythropoietic Protoporphyria</Disease_Name>
      <Disease_Detail>Erythropoietic Protoporphyria</Disease_Detail>
      <Disease_DB>ERY009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/erythropoietic_protoporphyria?search=CYP2E1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Beta Thalassemia</Disease_Name>
      <Disease_Detail>Beta Thalassemia</Disease_Detail>
      <Disease_DB>BTT002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/beta_thalassemia?search=CYP2E1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Alcohol Abuse</Disease_Name>
      <Disease_Detail>Alcohol Abuse</Disease_Detail>
      <Disease_DB>ALC004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/alcohol_abuse?search=CYP2E1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Oral Cancer</Disease_Name>
      <Disease_Detail>Oral Cancer</Disease_Detail>
      <Disease_DB>ORL011</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/oral_cancer?search=CYP2E1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Benzene Toxicity</Disease_Name>
      <Disease_Detail>Benzene Toxicity</Disease_Detail>
      <Disease_DB>BNZ002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/benzene_toxicity?search=CYP2E1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Alcoholic Liver Cirrhosis</Disease_Name>
      <Disease_Detail>Alcoholic Liver Cirrhosis</Disease_Detail>
      <Disease_DB>ALC009</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/alcoholic_liver_cirrhosis?search=CYP2E1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Alcoholic Hepatitis</Disease_Name>
      <Disease_Detail>Alcoholic Hepatitis</Disease_Detail>
      <Disease_DB>ALC006</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/alcoholic_hepatitis?search=CYP2E1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Cardia Cancer</Disease_Name>
      <Disease_Detail>Cardia Cancer</Disease_Detail>
      <Disease_DB>CRD005</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/cardia_cancer?search=CYP2E1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Drug-Induced Hepatitis</Disease_Name>
      <Disease_Detail>Drug-Induced Hepatitis</Disease_Detail>
      <Disease_DB>DRG002</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/drug_induced_hepatitis?search=CYP2E1#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Tuberculosis</Disease_Name>
      <Disease_Detail>Tuberculosis</Disease_Detail>
      <Disease_DB>TBR010</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/tuberculosis?search=CYP2E1#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Human Cytochrome P450 2E1 in Complex with Omega-Imidazolyl-Dodecanoic Acid</PDB_Title>
      <PDB_ID>3LC4</PDB_ID>
      <Resolution>3.1</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3LC4</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Human cytochrome P450 2E1 structures with fatty acid analogs reveal a previously unobserved binding mode.</PubMed_Title>
      <Author>Porubsky, P.R., et al.</Author>
      <Journal>J.Biol.Chem.(2010)285:22282-22290</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20463018?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human cytochrome P450 2E1 in complex with omega-imidazolyl-decanoic acid</PDB_Title>
      <PDB_ID>3GPH</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3GPH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Human cytochrome P450 2E1 structures with fatty acid analogs reveal a previously unobserved binding mode.</PubMed_Title>
      <Author>Porubsky, P.R., et al.</Author>
      <Journal>J.Biol.Chem.(2010)285:22282-22290</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20463018?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human cytochrome P450 2E1 in complex with the inhibitor indazole</PDB_Title>
      <PDB_ID>3E6I</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3E6I</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of human cytochrome P450 2E1: insights into the binding of inhibitors and both small molecular weight and fatty acid substrates.</PubMed_Title>
      <Author>Porubsky, P.R., et al.</Author>
      <Journal>J.Biol.Chem.(2008)283:33698-33707</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18818195?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human cytochrome P450 2E1 in complex with the inhibitor 4-methylpyrazole</PDB_Title>
      <PDB_ID>3E4E</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3E4E</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structures of human cytochrome P450 2E1: insights into the binding of inhibitors and both small molecular weight and fatty acid substrates.</PubMed_Title>
      <Author>Porubsky, P.R., et al.</Author>
      <Journal>J.Biol.Chem.(2008)283:33698-33707</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/18818195?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human Cytochrome P450 2E1 in complex with pilocarpine</PDB_Title>
      <PDB_ID>3T3Z</PDB_ID>
      <Resolution>2.35</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3T3Z</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural comparison of cytochromes P450 2A6, 2A13, and 2E1 with pilocarpine.</PubMed_Title>
      <Author>DeVore, N.M., et al.</Author>
      <Journal>Febs J.(2012)279:1621-1631</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22051186?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Cytochrome P450 2E1 with omega-imidazolyl octanoic acid</PDB_Title>
      <PDB_ID>3KOH</PDB_ID>
      <Resolution>2.9</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3KOH</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Human cytochrome P450 2E1 structures with fatty acid analogs reveal a previously unobserved binding mode.</PubMed_Title>
      <Author>Porubsky, P.R., et al.</Author>
      <Journal>J.Biol.Chem.(2010)285:22282-22290</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20463018?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00591</Pathway_ID>
      <Pathway_Title>Linoleic acid metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Lipid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00982</Pathway_ID>
      <Pathway_Title>Drug metabolism - cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00591</Pathway_ID>
      <Pathway_Title>Linoleic acid metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Lipid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00590</Pathway_ID>
      <Pathway_Title>Arachidonic acid metabolism</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Lipid metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05204</Pathway_ID>
      <Pathway_Title>Chemical carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00982</Pathway_ID>
      <Pathway_Title>Drug metabolism - cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04932</Pathway_ID>
      <Pathway_Title>Non-alcoholic fatty liver disease (NAFLD)</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Endocrine and metabolic diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05204</Pathway_ID>
      <Pathway_Title>Chemical carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko00980</Pathway_ID>
      <Pathway_Title>Metabolism of xenobiotics by cytochrome P450</Pathway_Title>
      <Pathway_Class>Metabolism</Pathway_Class>
      <Pathway_Subclass>Xenobiotics biodegradation and metabolism</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05204</Pathway_ID>
      <Pathway_Title>Chemical carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <CATH_Class>Class 1: Mainly Alpha </CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/3e4e</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Detail>site,299,Ala;site,303,Thr;site,437,Cys</Site_Detail>
      <Site_Reference>Hartman JH, et al. Drug Metab Dispos. 2012 Jul 17. [Epub ahead of print]</Site_Reference>
      <PubMed_ID>22807108</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>1.14.13.-</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC1/14/13/-.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD09470001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2013-04-23</Create_Date>
</Organism_Record>